Sinco Pharmaceuticals Holdings Balance Sheet Health
Financial Health criteria checks 6/6
Sinco Pharmaceuticals Holdings has a total shareholder equity of CN¥628.1M and total debt of CN¥241.7M, which brings its debt-to-equity ratio to 38.5%. Its total assets and total liabilities are CN¥1.9B and CN¥1.3B respectively. Sinco Pharmaceuticals Holdings's EBIT is CN¥116.5M making its interest coverage ratio 30.3. It has cash and short-term investments of CN¥437.9M.
Key information
38.5%
Debt to equity ratio
CN¥241.74m
Debt
| Interest coverage ratio | 30.3x |
| Cash | CN¥437.92m |
| Equity | CN¥628.05m |
| Total liabilities | CN¥1.26b |
| Total assets | CN¥1.89b |
Recent financial health updates
Does Sinco Pharmaceuticals Holdings (HKG:6833) Have A Healthy Balance Sheet?
Nov 07
Does Sinco Pharmaceuticals Holdings (HKG:6833) Have A Healthy Balance Sheet?
May 30Sinco Pharmaceuticals Holdings (HKG:6833) Has A Pretty Healthy Balance Sheet
Oct 26Sinco Pharmaceuticals Holdings (HKG:6833) Could Easily Take On More Debt
May 24Recent updates
Some Investors May Be Willing To Look Past Sinco Pharmaceuticals Holdings' (HKG:6833) Soft Earnings
Apr 02Sinco Pharmaceuticals Holdings Limited (HKG:6833) Might Not Be As Mispriced As It Looks
Mar 08Does Sinco Pharmaceuticals Holdings (HKG:6833) Have A Healthy Balance Sheet?
Nov 07A Look At The Intrinsic Value Of Sinco Pharmaceuticals Holdings Limited (HKG:6833)
Jun 26Does Sinco Pharmaceuticals Holdings (HKG:6833) Have A Healthy Balance Sheet?
May 30Sinco Pharmaceuticals Holdings (HKG:6833) Has A Pretty Healthy Balance Sheet
Oct 26Here's Why I Think Sinco Pharmaceuticals Holdings (HKG:6833) Might Deserve Your Attention Today
Feb 04I Ran A Stock Scan For Earnings Growth And Sinco Pharmaceuticals Holdings (HKG:6833) Passed With Ease
Oct 25Little Excitement Around Sinco Pharmaceuticals Holdings Limited's (HKG:6833) Earnings
Jun 10Sinco Pharmaceuticals Holdings (HKG:6833) Could Easily Take On More Debt
May 24Here's Why I Think Sinco Pharmaceuticals Holdings (HKG:6833) Is An Interesting Stock
Apr 20We're Not So Sure You Should Rely on Sinco Pharmaceuticals Holdings' (HKG:6833) Statutory Earnings
Feb 16How Much Did Sinco Pharmaceuticals Holdings'(HKG:6833) Shareholders Earn From Share Price Movements Over The Last Three Years?
Jan 11
Should You Be Excited About Sinco Pharmaceuticals Holdings Limited's (HKG:6833) 51% Return On Equity?
Dec 07Financial Position Analysis
Short Term Liabilities: 6833's short term assets (CN¥1.4B) exceed its short term liabilities (CN¥1.2B).
Long Term Liabilities: 6833's short term assets (CN¥1.4B) exceed its long term liabilities (CN¥30.6M).
Debt to Equity History and Analysis
Debt Level: 6833 has more cash than its total debt.
Reducing Debt: 6833's debt to equity ratio has reduced from 638.1% to 38.5% over the past 5 years.
Debt Coverage: 6833's debt is well covered by operating cash flow (146.3%).
Interest Coverage: 6833's interest payments on its debt are well covered by EBIT (30.3x coverage).